Potential of vitamin D in treating diabetic cardiomyopathy

Ting-Wei Lee1, Ting-I Lee2, Chun-Jen Chang3

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Insights

Vitamin D may offer a potential treatment for diabetic cardiomyopathy, improving cardiovascular outcomes in diabetes through various beneficial activities. However, further large-scale clinical trials are needed to confirm its efficacy and safety.

Area of Science:

  • Cardiology
  • Endocrinology
  • Nutritional Science

Background:

  • Diabetic cardiomyopathy is a significant complication of diabetes mellitus (DM), leading to high rates of cardiovascular morbidity and mortality.
  • Current therapeutic options for diabetic cardiomyopathy are limited, necessitating the exploration of novel treatment strategies.

Purpose of the Study:

  • To review and evaluate existing research on the role of vitamin D in the context of diabetic cardiomyopathy.
  • To explore the metabolism, molecular, cellular, and neuroendocrine effects of vitamin D in relation to cardiovascular health in diabetes.

Main Methods:

  • A comprehensive literature search was conducted using the PubMed database.
  • The review synthesized findings on vitamin D metabolism, its effects on cardiovascular systems, and its potential therapeutic role in diabetes and cardiovascular disease.

Main Results:

  • Vitamin D may improve cardiovascular outcomes in diabetic patients via anti-inflammatory, antioxidative, antihypertrophic, antifibrotic, and antiatherosclerotic mechanisms.
  • It also influences pathways including advanced glycation end-product signaling, the renin-angiotensin system, and cardiac metabolism.
  • Evidence suggests vitamin D as a potential therapeutic agent for diabetic cardiomyopathy, though risks like hypercalcemia exist.

Conclusions:

  • Vitamin D demonstrates potential benefits for treating diabetic cardiomyopathy by addressing multiple pathological pathways.
  • Further large-scale randomized clinical trials are essential to validate these findings and establish optimal usage in well-defined diabetic patient populations.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
711
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
909
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.6K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
9.0K